1102 related articles for article (PubMed ID: 7761104)
1. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
Su ZZ; Yemul S; Stein CA; Fisher PB
Oncogene; 1995 May; 10(10):2037-49. PubMed ID: 7761104
[TBL] [Abstract][Full Text] [Related]
2. Effect of methyl methanesulfonate on type 5 adenovirus DNA integration and the phenotypic properties of cold-sensitive type 5 adenovirus-transformed cloned rat embryo fibroblast cells.
Hermo H; Duigou GJ; Zimmer SG; Fisher PB
Cancer Res; 1988 Jun; 48(11):3050-7. PubMed ID: 3365695
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels.
Gruebele A; Zawaski K; Kaplan D; Novak RF
Drug Metab Dispos; 1996 Jan; 24(1):15-22. PubMed ID: 8825185
[TBL] [Abstract][Full Text] [Related]
4. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
Dosch J; Kaina B
Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of carcinogen enhancement of type 5 adenovirus transformation of cloned Fischer rat embryo fibroblast cells.
Su ZZ; Shen R; Young CS; Fisher PB
Mol Carcinog; 1993; 8(3):155-66. PubMed ID: 8216734
[TBL] [Abstract][Full Text] [Related]
6. Early events in methyl methanesulfonate enhancement of adenovirus transformation of cloned rat embryo fibroblast cells.
Su ZZ; Fisher PB
Mol Carcinog; 1989; 2(5):252-60. PubMed ID: 2604863
[TBL] [Abstract][Full Text] [Related]
7. Unique carcinogen enhancement of transformation phenotype displayed by cloned rat embryo fibroblast (CREF) cells treated with methyl methanesulfonate and infected with a specific host-range mutant of type 5 adenovirus.
Hermo H; Duigou GJ; Babiss LE; Fisher PB
Carcinogenesis; 1987 Jul; 8(7):967-75. PubMed ID: 3594729
[TBL] [Abstract][Full Text] [Related]
8. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
Kim R; Beck WT
Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863
[TBL] [Abstract][Full Text] [Related]
9. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins.
Li H; Xie P; Li G; Hao L; Xiong Q
Toxicon; 2009 Jan; 53(1):169-75. PubMed ID: 19041662
[TBL] [Abstract][Full Text] [Related]
10. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
Whisler RL; Chen M; Beiqing L; Carle KW
Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
[TBL] [Abstract][Full Text] [Related]
11. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
12. Stable induction of c-jun mRNA expression in normal human keratinocytes by agents that induce predifferentiation growth arrest.
Blatti SP; Scott RE
Cell Growth Differ; 1992 Jul; 3(7):429-34. PubMed ID: 1419906
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
Morello D; Lavenu A; Babinet C
Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
[TBL] [Abstract][Full Text] [Related]
14. Effects of immortalization upon the induction of matrix metalloproteinases in rabbit synovial fibroblasts.
Lin CW; Robbins PD; Georgescu HI; Evans CH
Exp Cell Res; 1996 Feb; 223(1):117-26. PubMed ID: 8635483
[TBL] [Abstract][Full Text] [Related]
15. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
[TBL] [Abstract][Full Text] [Related]
16. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
17. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
18. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
Rameh LE; Armelin MC
Oncogene; 1991 Jun; 6(6):1049-56. PubMed ID: 1648700
[TBL] [Abstract][Full Text] [Related]
19. Mitogenesis of quiescent chick fibroblasts by v-Src: dependence on events at the membrane leading to early changes in AP-1.
Catling AD; Wyke JA; Frame MC
Oncogene; 1993 Jul; 8(7):1875-86. PubMed ID: 8510932
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1).
Hass R; Brach M; Kharbanda S; Giese G; Traub P; Kufe D
J Cell Physiol; 1991 Oct; 149(1):125-31. PubMed ID: 1939341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]